NEWS Archives - NexPoint

NexPoint Merger Arbitrage Fund Earns Spot on HFM U.S. Performance Awards Shortlist in Two Categories

DALLAS, Sept. 18, 2023 /PRNewswire/ -- NexPoint, a multibillion-dollar alternative investment firm, announced today that the NexPoint Merger…

mmarschikSeptember 18, 2023

FEATURED Life Sciences NEWS PRESS RELEASE

NexPoint Announces Co-investment in NexPoint Life Sciences II DST, Continuing Commitment to Life Sciences with a Focus on CDMOs and cGMP Facilities

DALLAS, Sept. 12, 2023 /PRNewswire/ -- NexPoint, a multibillion-dollar alternative investment platform, announces it has made an initial…

mmarschikSeptember 12, 2023

Dallas FEATURED NEWS PRESS RELEASE

$4 Billion Redevelopment of Plano’s Former EDS HQ Gains Zoning Panel Approval

According to The Dallas Morning News, Plano’s planning commission has approved the $4 billion rezoning…

mmarschikJuly 21, 2023

NexPoint Expands Industrial Real Estate Footprint with Acquisition of Four Small Bay Multi-Tenant Properties in Central Florida

Properties are comprised of small bay industrial multi-tenant assets in Tampa and Orlando DALLAS, June 20, 2023 /PRNewswire/ -- NexPoint, a…

mmarschikJune 21, 2023

NEWS NexPoint Capital PRESS RELEASE

NexPoint Capital, Inc. Announces Tender Offer for Common Stock

DALLAS, May 19, 2023 /PRNewswire/ -- NexPoint Capital, Inc. (the "Company"), a non-traded publicly registered business development…

mmarschikMay 19, 2023

Life Sciences NEWS PRESS RELEASE

NexPoint’s Life Sciences Project in Plano, Texas Renamed Texas Research Quarter

DALLAS, May 18, 2023 /PRNewswire/ -- NexPoint, a multibillion-dollar alternative investment firm, today announced that its cutting-edge…

mmarschikMay 18, 2023

FEATURED Life Sciences NEWS PRESS RELEASE

NexPoint Expands Life Sciences Real Estate Footprint with Acquisition of Two Properties from Adare Pharma Solutions

Properties were indirectly acquired by NexPoint Life Sciences II DST, a Delaware statutory trust seeking to raise $42…

mmarschikMay 17, 2023

FEATURED Life Sciences NEWS PRESS RELEASE

Featured Video: Focus on Alternatives: Real Estate Investing in Life Sciences

In an interview with ADISA board member Greg Mausz, Nexpoint’s chief financial officer and executive…

mmarschikApril 27, 2023

FEATURED NEWS NexPoint Storage PRESS RELEASE

NexPoint Launches Fourth Self-Storage DST Offering with Three Premium Assets

NexPoint Storage IV comprises three GenV assets in Arizona and Florida MSAs with population growth potential.…

mmarschikApril 17, 2023

NEWS NexPoint Capital PRESS RELEASE

NexPoint Capital, Inc. Announces Tender Offer for Common Stock

DALLAS, March 30, 2023 /PRNewswire/ -- NexPoint Capital, Inc. (the "Company"), a non-traded publicly registered business development…

mmarschikMarch 30, 2023

Form CRS | Important Disclosures | Privacy Policy

Before investing in any of the NexPoint funds, you should carefully consider the fund’s investment objectives, risks, charges, and expenses. A copy of a fund’s prospectus, which contains this and other information, is available on the fund’s website or by calling the shareholder services at (844) 485-9167.

Please read the prospectus carefully before investing. This website is neither an offer to sell nor a solicitation of an offer to buy any of the securities described herein. An investment in any of the NexPoint offerings involves risk, and there can be no assurance that the investment objectives will be met. Past performance does not guarantee future results.

NexPoint Securities, Inc., Member FINRA/SIPC, is the distributor for NexPoint products

NEWS

Follow NexPoint on LinkedIn